Many Ways to Support HOPA
From the Industry Relations Council (IRC) corporate sponsorship, to HOPA's Annual Conference, to a la carte advertising, there are many ways to support HOPA and connect with our members.
At nearly 4,000 members strong, HOPA is 100% dedicated to supporting oncology pharmacists and optimizing patient care. We believe everyone undergoing cancer treatment should have an oncology pharmacist as an integral member of their care team. Through robust education and professional development, active advocacy, and industry support, our members are poised to make that vision a reality.
Industry Relations Council
HOPA's signature opportunity for industry support continues to be our Industry Relations Council (IRC), complete with benefits such as high visibility at conferences and events. Click here to learn more.
IRC participation is open to all organizations that support HOPA's mission and goals. Contact Laurie Rappa, Senior Development Manager, at (877) 467-2791 or lrappa@hoparx.org with inquiries.
HOPA 2026 Annual Conference Prospectus
The full 2026 Annual Conference Prospectus is now available! If you would like to join our conference contact mailing list or request a copy of the prospectus, please email development@hoparx.org.
Last day to secure opportunities for HOPA 2026 Annual Conference is February 27, 2026.
Click here to learn more about Annual Conference sponsor and exhibitor opportunities.
HOPA Annual Conference 2026
HOPA Annual Conference 2026 (HOPA 2026) takes place March 25-27, 2026, at the New Orleans Morial Convention Center in New Orleans, LA. This conference is known for its late-breaking and diverse content delivered by oncology pharmacy professionals who are experts in optimizing care of patients with cancer and hematologic conditions.
In addition to all the great science delivered in plenary and breakout sessions, and presented in posters and abstracts, we also look forward to networking with members, colleagues, and industry partners like you! Thank you for considering these opportunities:
- Become a conference sponsor
- Promote your company and products in the Exhibit Hall
- Present a CE or Non-CE Symposia (reservations open for 2026)
- Be Visible – Check out in person and online advertising opportunities
Annual Conference opportunities are available on a first come first served basis. Our early bird prospectus launched in June and our full prospectus is scheduled to launch in September. Click here to be added to our prospectus mailing list. If you're ready to get started, please complete our sponsorship form. The last day to reserve HOPA 2026 Annual Conference opportunities is February 27, 2026.
HOPA 2025 Conference Highlights
Last year we had a record breaking 1,700 registrants!
- Attendees will had ample learning opportunities, including 34 ACPE credits and 8 BCOP credits
- HOPA 2025 also hosted two pre-conference sessions, focusing on leadership development and chemotherapy toxicity (each session provides an additional 4 ACPE credit hours)
- Conference session were of interest to both general and sub-specialist hematology/oncology pharmacists, focusing on a wide variety of cancers including pediatric cancers, NSCLC, and CLL
- Topics covered various treatment types, including cellular therapy and novel therapies, as well as practice management learning
- Additional topics included supportive care management and clinical practice updates on several disease states
Industry Encore Posters
Industry supported posters and encore submissions are considered through HOPA’s education team if they meet all of the requirements, including having a member of HOPA as the author/presenter. More information on these categories can be found HOPA's website. Categories include trainee research, late-breaking research, and completed research. Please reach out to our education department education@hoparx.org for any questions regarding these categories.
In addition to these categories, HOPA also has the Industry Encore Poster category through our development team. These posters are a benefit available to participating Industry Relations Council (IRC) Partners. Industry Encore Posters are posters that have been accepted and presented at other professional meetings and/or previously published and are submitted by one of HOPA’s Industry Relations Council (IRC) Partners. Information for the Industry Encore poster category for HOPA's Annual Conference 2026 will be available in the fall. The full Industry Encore Poster Guidelines will be available in late October and distributed to our IRC contacts. IRC partners choose which posters they would like to submit for the Industry Encore Poster category. The number of allowed submissions varies depending on IRC level.
Learn More
Continue reading about more partnership opportunities with HOPA here!
Contact HOPA
If you have any questions or would like more information, please contact the HOPA Development Team at development@hoparx.org.
The Importance of Industry Support
HOPA's Time to Talk initiative
One example of what HOPA is able to achieve with a little bit of support is the Time to Talk Initiative.
HOPA's current Time to Talk campaign focuses on clinical trials. If your company is interested in supporting this campaign, reach out to development@hoparx.org for more information.
Learn more about our past Time to Talk campaigns:
Industry as a Career
HOPA member Jeremy Whalen, PharmD, BCOP, Medical Affairs Executive Director for Genentech, discusses the intersection of a career in industry and his commitment to HOPA.